[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![OzmosiHealth Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1055982930.png) Ozmosi [@OzmosiHealth](/creator/twitter/OzmosiHealth) on x 2626 followers
Created: 2025-07-16 02:02:20 UTC

Akeso has enrolled the first patient in Phase III trial (AK112-312/HARMONi-GI6) for Ivonescimab in advanced metastatic colorectal cancer treatment.

More Info: $XBI $IBB $XPH $PPH

![](https://pbs.twimg.com/media/Gv8audsWgAADuq_.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945302953881165975/c:line.svg)

**Related Topics**
[$pph](/topic/$pph)
[$xph](/topic/$xph)
[$ibb](/topic/$ibb)
[$xbi](/topic/$xbi)
[more info](/topic/more-info)
[$9926hk](/topic/$9926hk)

[Post Link](https://x.com/OzmosiHealth/status/1945302953881165975)